An obesity drug sibutramine reduces brain natriuretic peptide (BNP) levels in severely obese patients

International Journal of Clinical Practice

Volumn 64, Issue 4, 2010, Pages 518-522

  Taner Ertugrul, D ^a   Yavuz, B ^a   Okhan Akin, K ^a   Arif Yalcin, A ^a   Ata, N ^a   Kucukazman, M ^a   Algul, B ^a   Dal, K ^a   Sinan Deveci, O ^a   Tutal, E ^a  

^a Kecioren Teaching and Research Hospital ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIBUTRAMINE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

APPETITE DEPRESSANTS; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLESTEROL, LDL; CYCLOBUTANES; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OBESITY;

EID: 76349084263     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02197.x     Document Type: Article

References (20)

1. Kenchaiah S, Evans JC, Levy D et al. Obesity and the risk of heart failure. N Engl J Med 2002 347 : 305 313.
2. Avelar E, Cloward TV, Walker JM et al. Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass. Hypertension 2007 49 : 34 9.
3. Dandona P, Chaudhuri A, Ghanim H, Mohanty P. Use of insulin to improve glycemic control in diabetes mellitus. Cardiovasc Drugs Ther 2008 22 (3 241 251.
4. Cheung BM, Kumana CR. Natriuretic peptides: relevance in cardiac disease. JAMA 1998 280 : 1983 1984.
5. Mehra MR, Uber PA, Park MH et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004 43 : 1590 1595.
6. Van Kimmenade R, van Dielen F, Bakker J et al. Is brain natriuretic peptide production decreased in obese subjects? J Am Coll Cardiol 2006 47 : 886 887.
7. Arterburn DE, Crane PK, Veenstra DL. The efficacy and safety of sibutramine for weight loss: a systematic review. Arch Intern Med 2004 164 : 994 1003.
8. McNeely W, Goa KL. Sibutramine. A review of its contribution to the management of obesity. Drugs 1998 56 : 1093 1124. (Pubitemid 29010230)
9. Lean ME. How does sibutramine work? Int J Obes Relat Metab Disord 2001 25 : S8 11.
10. Solomon CG, Manson JE. Obesity and mortality: a review of the epidemiologic data. Am J Clin Nutr 1997 66 : 1044S 50S.
11. Klein S, Burke LE, Bray GA et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004 110 : 2952 2967.
12. Pi-Sunyer FX. The epidemiology of central fat distribution in relation to disease. Nutr Rev 2004 62 : S120 6.
13. Liberopoulos EN, Mikhailidis DP, Elisaf MS. Diagnosis and management of the metabolic syndrome in obesity. Obes Rev 2005 6 : 283 296.
14. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 346 : 393 403.
15. Alpert MA, Hashimi MW. Obesity and the heart. Am J Med Sci 1993 306 : 117 123.
16. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001 38 : 789 795.
17. Bray GA, Blackburn GL, Ferguson JM et al. Sibutramine produces dose-related weight loss. Obes Res 1999 7 : 189 198.
18. Sengenes C, Moro C, Galitzky J, Berlan M, Lafontan M. Natriuretic peptides: a new lipolytic pathway in human fat cells. Med Sci (Paris) 2005 21 (1 61 5. Review. French.
19. Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A. Thermogenic effects of sibutramine in humans. Am J Clin Nutr 1998 68 : 1180 1186.
20. Nakamura Y, Yoshizawa H, Hirasawa M, Kida H, Matsumoto Y, Ueyama T. Effect of endoscopic transthoracic sympathicotomy on plasma natriuretic peptide concentrations in humans. Circ J 2005 69 (9 1079 1083.